Venture Capital Investors

Erasca Ventures

Erasca Ventures makes VC investments in companies focused on high-impact, technology-driven solutions.

Venture Investor Overview

Contact Information

Background Information

Overview

Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's pipeline includes two clinical-stage programs (ERK and SHP2 inhibitors), two preclinical-stage programs (CNS-penetrant KRAS G12C and EGFR inhibitors), and seven discovery-stage programs targeting other key oncogenic drivers.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

3/22/2022

Transaction History

Our records indicate that Erasca Ventures invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Investor Contacts

Title

Name

Email & Social

Senior Vice President of Finance

Brian Baker

        

Vice President of Clinical Development

Les Brail

        

Chief Financial Officer

David Chacko

        

CEO

Jonathan E. Lim

        

Chief Medical Officer

Wei Lin

        

Chief People Officer

isa Tesvich-Bonora

        

Chair of R&D

Michael Varney

        

Funds

No fund closings have been recorded for this company.

Portfolio Companies

Erasca Ventures has invested in only one tech company, according to our database records. If we are missing a portfolio company, please let us know.

Browse more venture capital investors:

era.ventures | Eren Groupe

Share this article

About Our VC Investor Database

This VC firm profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary